tiprankstipranks
Black Bird Biotech (BBBT)
OTHER OTC:BBBT
US Market
Holding BBBT?
Track your performance easily

Black Bird Biotech (BBBT) Income Statement

28 Followers

Black Bird Biotech Income Statement

Last quarter (Q ), Black Bird Biotech's total revenue was $3.94K, a decrease of -84.70% from the same quarter last year. In Q, Black Bird Biotech's net income was $-131.23K. See Black Bird Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 36.32K$ 82.56K$ 104.46K$ 57.60K$ 18.07K-
Cost of Revenue
$ 23.02K$ 49.55K$ 84.87K$ 28.25K$ 17.80K-
Gross Profit
$ 13.31K$ 33.01K$ 19.59K$ 29.36K$ 269.00-
Operating Expense
$ 382.98K$ 1.32M$ 1.47M$ 714.16K$ 112.32K$ 83.54K
Operating Income
$ -369.67K$ -1.29M$ -1.45M$ -684.80K$ -112.05K$ -83.54K
Net Non Operating Interest Income Expense
$ -521.88K$ -370.59K$ -285.33K$ -5.87K$ -4.46K$ -37.57K
Other Income Expense
$ -69.13K$ -154.00$ 74.85K$ -99.00K--
Pretax Income
$ -804.98K$ -1.66M$ -1.81M$ -621.66K$ -149.37K$ -121.11K
Tax Provision
-----$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -820.92K$ -1.66M$ -1.81M$ -690.16K$ -149.37K$ -121.11K
Basic EPS
------
Diluted EPS
------
Basic Average Shares
$ 2.94B$ 330.73M$ 194.42M$ 120.36M$ 85.97M$ 85.97M
Diluted Average Shares
$ 6.12B$ 806.45M$ 225.54M$ 132.55M$ 85.97M$ 85.97M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 35.89K$ 1.37M$ 1.56M$ 742.41K$ 130.12K$ 83.54K
Net Income From Continuing And Discontinued Operation
$ -836.14K$ -1.66M$ -1.81M$ -690.16K$ -149.37K$ -121.11K
Normalized Income
$ -99.05K-----
Interest Expense
------
EBIT
$ -187.80K$ -1.29M$ -1.53M$ -684.28K$ -149.37K$ -83.54K
EBITDA
$ 99.72K$ -1.20M$ -1.42M$ -684.28K$ -149.37K$ -83.54K
Currency in USD

Black Bird Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis